Dimensional Fund Advisors’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.2M Buy
394,447
+170,872
+76% +$11.9M 0.01% 1862
2025
Q4
$17.7M Sell
223,575
-6,848
-3% -$579K ﹤0.01% 2031
2025
Q3
$15.2M Buy
230,423
+37,567
+19% +$2.23M ﹤0.01% 2132
2025
Q2
$10.2M Buy
192,856
+53,463
+38% +$2.51M ﹤0.01% 2271
2025
Q1
$6.92M Sell
139,393
-327
-0.2% -$18.2K ﹤0.01% 2392
2024
Q4
$8.86M Buy
139,720
+86,154
+161% +$4.98M ﹤0.01% 2354
2024
Q3
$2.63M Buy
+53,566
New +$2.51M ﹤0.01% 2717

Other funds holding IRON

Dimensional Fund Advisors's IRON Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Disc Medicine (IRON) stake by 76% in Q1 2026, buying an estimated $11.9M and bringing the position to 394,447 shares worth $25.2M. The position accounts for 0.01% of the portfolio, ranked #1862.

Dimensional Fund Advisors first reported a position in IRON in Q3 2024 and has held it in 7 quarters since. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Dimensional Fund Advisors held 394,447 shares of Disc Medicine worth $25.2M as of Q1 2026.
  • Dimensional Fund Advisors bought 170,872 Disc Medicine shares in Q1 2026, an estimated $11.9M.
  • Disc Medicine made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1862 holding.
  • Dimensional Fund Advisors first reported a position in Disc Medicine in Q3 2024 and has held it in 7 quarters since.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.